Biogen Inc.
(NASDAQ : BIIB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
TSROTESARO, Inc.
0.48%74.0114.4%$594.12m
AMGNAmgen Inc.
-0.11%189.881.2%$550.70m
GILDGilead Sciences, Inc.
1.86%66.330.9%$545.40m
CELGCelgene Corporation
-0.69%67.661.2%$490.54m
ILMNIllumina, Inc.
1.22%314.693.5%$343.68m
BIIBBiogen Inc.
-4.85%297.921.3%$338.47m
REGNRegeneron Pharmaceuticals, Inc.
0.77%378.392.6%$271.14m
VRTXVertex Pharmaceuticals Incorporated
1.58%168.791.9%$216.75m
AAgilent Technologies, Inc.
0.94%68.491.5%$216.57m
ALXNAlexion Pharmaceuticals, Inc.
-0.55%108.932.0%$152.98m
INCYIncyte Corporation
2.01%66.122.5%$99.12m
EXASExact Sciences Corporation
-0.75%66.6125.3%$93.00m
BLUEBluebird Bio, Inc.
-1.88%102.6014.4%$85.87m
SRPTSarepta Therapeutics, Inc.
-0.88%114.6815.4%$83.71m
GBTGlobal Blood Therapeutics Inc
0.58%41.817.0%$81.31m

Company Profile

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.